Jeffrey Loh‑Doyle, MD is a urologic oncologist at Keck Medicine of USC and a member of the multidisciplinary team at USC Norris Comprehensive Cancer Center, one of the nation’s leading cancer centers.

Dr. Loh-Doyle specializes in the diagnosis and treatment of prostate, kidney, and bladder cancers, with particular expertise in minimally invasive and robotic-assisted surgery. His clinical work focuses on helping patients navigate complex treatment decisions while maintaining quality of life.

In addition to his surgical practice, Dr. Loh-Doyle is involved in clinical research and medical education at the Keck School of Medicine of USC, where he works with multidisciplinary teams to advance treatments and outcomes for patients with urologic cancers.

Dr. Weidhaas, a co-founder of MiraDx and professor at UCLA, leads translation research in radiation oncology. Her pioneering research led to the co-discovery of the KRAS-variant, a strong predictor of cancer risk, tumor biology, and treatment response. She co-founded MiraDx and MiraKind to empower individuals with meaningful health information. Joanne completed her oncology training at Memorial Sloan-Kettering Cancer Center and previously served as Chief of the Breast Cancer Radiation Service at Yale Cancer Center. She completed an MSM at Stanford University during a sabbatical at Yale. She moved to UCLA as Professor and Division Head, Translational Research, in 2014. Her dual role as a clinician and researcher applies genetic breakthroughs to patient benefit. She currently resides in the LA area with her husband and three children.

Dr. Szabo is widely recognized for his leadership in advancing transperineal prostate biopsy, a technique that improves prostate cancer detection while significantly reducing the risk of infection compared with traditional approaches.

He has published and taught extensively on performing office-based, local-anesthesia transperineal biopsy and has helped train urologists in adopting this safer diagnostic method.